Kidney Cancer Caki-1 Transfection Kit
Kit size Volume | Quantity | ||
---|---|---|---|
0.5 ml(Cat-172258) | Inquiry | Add to cart | |
1.5 ml(Cat-172259) | Inquiry | Add to cart | |
8.0 ml(Cat-172266) | Inquiry | Add to cart | |
1.5 ml CRISPR(Cat-212262) | Inquiry | Add to cart |
Description
Product Information
Description
Kidney cancer is a major public health problem. Clear cell carcinoma accounts for 92 percent of renal cell carcinoma cases, the most common form of kidney cancer, according to the study. The Caki-1 cell line is a renal clear cell carcinoma cell line with an epithelial cell morphology that has been shown to be a reliable transfection host. The cell line was established from renal carcinoma cells in a 49-year-old Caucasian male patient with clear cell carcinoma. Caki-1 tumorigenic cells are commonly used to study human proximal tubular epithelial cells. These cells contain many microvilli but few filaments. In addition, Caki-1 cells have many small mitochondria and well-developed Golgi apparatus and endoplasmic reticulum (ER). In order to facilitate in-depth research, a specific and efficient cell transfection system is essential. To this end, CD BioSciences has developed a specific transfection kit for the Calu-3 cell line.